News Steve Paul reignites xanomeline research as Karuna CEO Karuna aims to overcome safety concerns with combination therapy
News Samsung Bioepis and Takeda begin first trial from R&D tie-up Companies signed risk-sharing deal last year
News Sarepta dives deeper into gene therapy Sarepta Therapeutics has handed $30 million to Lacerta in exchange for a group of gene therapies, including a Pompe disease candidate.
News Spark shares tank after haemophilia gene therapy safety sign... Biotech still pressing on with late stage trials
News Lundbeck brings third Parkinson's drug into clinic Denmark’s Lundbeck is bringing a third potential drug for Parkinson’s disease to the clinic – a human antibody that the company hopes will tackle the underlying cause of the condition.
News Clock starts ticking on UK's single patient record plan In today's King's Speech, the UK government unveiled the NHS Modernisation Bill, starting the process of introducing a single patient record.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
